DAVID KAVANAUGH — Lobbyist Profile | Poliscope

DAVID KAVANAUGH

Reported covered position: Committee; Legislative Asst., Rep. Thomas

Filings

Clients

Firms

Years active

2011–2026

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
JOHNSON & JOHNSON SERVICES INC	63	2011–2026

Lobbying firms

Firm	Filings	Years
JOHNSON & JOHNSON SERVICES, INC.	63	2011–2026

Bills explicitly cited in this lobbyist’s assigned issues (100)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

Original LDA source filings (63)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2026 · third_quarter · Q3

Firm income: —Client expense: $2,220,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

DEF

Defense

- S.4784/H.R. 8800 National Defense Authorization Act (NDAA), regarding provision prohibiting Department of Defense (DOD) contracted companies from engaging in stock buybacks and issuing shareholder dividends absent a waiver from the Secretary

CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act, regarding all provisions Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees

Source: Senate LDA

H.R. 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1539

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

Show 96 more cited filings

H.R. 1539

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1539

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2214

DRUG Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2214

DRUG Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2214

DRUG Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2527

Early Detection of Vision Impairments for Children Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2527

Early Detection of Vision Impairments for Children Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2527

Early Detection of Vision Impairments for Children Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3006

To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3006

To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3006

To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3269

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3269

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3269

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3514

Improving Seniors’ Timely Access to Care Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3514

Improving Seniors’ Timely Access to Care Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3514

Improving Seniors’ Timely Access to Care Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3521

Clinical Trial Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3521

Clinical Trial Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3521

Clinical Trial Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3953

SBIR/STTR Website Improvement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4282

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4282

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4282

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4299

Protecting Patient Access to Cancer and Complex Therapies Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4299

Protecting Patient Access to Cancer and Complex Therapies Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4299

Protecting Patient Access to Cancer and Complex Therapies Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5256

340B ACCESS Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5256

340B ACCESS Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5256

340B ACCESS Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5343

Ensuring Patient Access to Critical Breakthrough Products Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5343

Ensuring Patient Access to Critical Breakthrough Products Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5343

Ensuring Patient Access to Critical Breakthrough Products Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5509

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5509

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5509

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5526

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5526

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5526

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6197

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6197

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6197

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6549

VA Contracting and Procurement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6549

VA Contracting and Procurement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6549

VA Contracting and Procurement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 7391

Community Health Center Drug Pricing Protection Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 7391

Community Health Center Drug Pricing Protection Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 7391

Community Health Center Drug Pricing Protection Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 8800

National Defense Authorization Act for Fiscal Year 2027

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 8800

National Defense Authorization Act for Fiscal Year 2027

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 929

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 929

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 929

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 946

ORPHAN Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 946

ORPHAN Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 946

ORPHAN Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HRES 1301

Supporting the designation of May 29, 2026, as "Mental Health Awareness in Agriculture Day" to raise awareness around mental health in the agricultural industry and workforce and to continue to reduce stigma associated with mental illness.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HRES 1301

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HRES 1301

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1040

Drug Competition Enhancement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1040

Drug Competition Enhancement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1040

Drug Competition Enhancement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1041

Affordable Prescriptions for Patients Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1041

Affordable Prescriptions for Patients Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1041

Affordable Prescriptions for Patients Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1097

Interagency Patent Coordination and Improvement Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1097

Interagency Patent Coordination and Improvement Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1097

Interagency Patent Coordination and Improvement Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1399

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1399

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1399

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1717

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1717

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1717

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1776

Medicare Beneficiary Co-Pay Fairness Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1776

Medicare Beneficiary Co-Pay Fairness Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1776

Medicare Beneficiary Co-Pay Fairness Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1874

Title VIII Nursing Workforce Reauthorization Act of 2026

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1954

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1954

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1954

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2003

Strengthening Benefit Plans Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2276

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2276

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2276

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2658

Medication Affordability and Patent Integrity Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2658

Medication Affordability and Patent Integrity Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2658

Medication Affordability and Patent Integrity Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 266

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 266

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 266

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2903

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2903

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2903

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 4784

National Defense Authorization Act for Fiscal Year 2027

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 4784

National Defense Authorization Act for Fiscal Year 2027

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act, regarding all provisions - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions - H.R. 3953 / S. 1874 Title VIII Nursing Workforce Reauthorization Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2026 · second_quarter · Q2

Firm income: —Client expense: $1,440,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

DEF

Defense

S.4784/H.R. 8800 National Defense Authorization Act (NDAA), regarding provision prohibiting Department of Defense (DOD) contracted companies from engaging in stock buybacks and issuing shareholder dividends absent a waiver from the Secretary

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms

TRD

Trade (domestic/foreign)

- Issues related to USMCA review and renegotiation

TAX

Taxation/Internal Revenue Code

Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax - use of excess pension funds

CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees

Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2026 · first_quarter · Q1

Firm income: —Client expense: $3,510,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms

CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees

TAX

Taxation/Internal Revenue Code

TRD

Trade (domestic/foreign)

- Issues related to USMCA review and renegotiation

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2025 · fourth_quarter · Q4

Firm income: —Client expense: $1,510,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property - patent thickets - patent fees

TAX

Taxation/Internal Revenue Code

Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax

TRD

Trade (domestic/foreign)

- Issues related to USMCA review and renegotiation

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office

Show 59 more original filings

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2025 · third_quarter · Q3

Firm income: —Client expense: $2,480,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TAX

Taxation/Internal Revenue Code

Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB

TRD

Trade (domestic/foreign)

- Issues related to USMCA review and renegotiation

HCR

Health Issues

CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including S. 1040, a bill to amend the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2025 · second_quarter · Q2

Firm income: —Client expense: $1,030,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954, Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments

CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions Issues related to - intellectual property, including S. 1040, a bill to amend the Federal Trade Commission Act to prohibit product hopping - Medication Affordability and Patent Integrity Act - patent thickets

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2025 · first_quarter · Q1

Firm income: —Client expense: $3,340,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in TCJA including in 2025 reconciliation bills

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. XXXX/ S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, H.R. XXX HELP Copays Act, regarding all provisions - H.R. 2214/ S. XXXX Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · fourth_quarter · Q4

Firm income: —Client expense: $1,520,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions. - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation. - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions. - S 1355/HR 2940, "PASTEUR Act", regarding all provisions. - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions. - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions. - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions. - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions. - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions. - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions. - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions. - HR 7174, "Ensuring Pathways to Innovative Cures (EPIC) Act", regarding all provisions - HR 8574, the "340B Affording Care for Communities and Ensuring a Strong Safety-Net (ACCESS) Act", regarding all provisions - HR 7384, "Creating Hope Reauthorization Act", regarding all provisions - HR 7153/ S 3679 the "Dr. Lorna Breen Health Care Provider Protection Reauthorization Act", regarding all provisions Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program - the SUSTAIN 340B Act

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · third_quarter · Q3

Firm income: —Client expense: $2,340,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · second_quarter · Q2

Firm income: —Client expense: $1,120,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TAX

Taxation/Internal Revenue Code

S 866/HR 2673, "American Innovation and R&D Competitiveness Act of 2023", regarding provisions related to research & development expensing. Issues related to: - OECD proposals on global tax & implementation - R&D expensing - Corporate tax provisions in TCJA - Corporate Alternative Minimum Tax implementation

TRD

Trade (domestic/foreign)

Issues related to: - Medical supply chains - TRIPS Waiver

CPT

- S 150, "Affordable Prescriptions for Patients Act of 2023", regarding all provisions. - S 79/HR 1717, "Interagency Patent Coordination and Improvement Act of 2023", regarding all provisions. - Issues related to intellectual property.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · first_quarter · Q1

Firm income: —Client expense: $2,730,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TRD

Trade (domestic/foreign)

Issues related to: - Medical supply chains - TRIPS Waiver

CPT

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions. - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation. - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions. - S 1355/HR 2940, "PASTEUR Act", regarding all provisions. - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions. - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions. - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions. - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions. - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions. - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions. - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions. Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - 340B - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · fourth_quarter · Q4

Firm income: —Client expense: $1,160,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TAX

Taxation/Internal Revenue Code

S 866/HR 2673, "American Innovation and R&D Competitiveness Act of 2023", regarding provisions related to research & development expensing Issues related to: - OECD proposals on global tax & implementation - R&D expensing - Corporate tax provisions in TCJA - Corporate Alternative Minimum Tax implementation

TRD

Trade (domestic/foreign)

Issues related to: - Medical supply chains - TRIPS Waiver

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions - S 1355/HR 2940, "PASTEUR Act", regarding all provisions - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - 340B - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · third_quarter · Q3

Firm income: —Client expense: $2,350,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

Issues related to: - medical supply chains - TRIPS Waiver

CPT

TAX

Taxation/Internal Revenue Code

S. 866/H.R. 2673, "American Innovation and R&D Competitiveness Act of 2023", regarding provisions related to research & development expensing. Issues related to: - OECD proposals on global tax & implementation - R&D expensing - corporate tax provisions in TCJA

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · second_quarter · Q2

Firm income: —Client expense: $850,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

CPT

TAX

Taxation/Internal Revenue Code

Issues related to: - OECD proposals on global tax & implementation - R&D expensing - corporate tax provisions in TCJA

TRD

Trade (domestic/foreign)

Issues related to: - medical supply chains - TRIPS Waiver

Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · first_quarter · Q1

Firm income: —Client expense: $2,490,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

Issues related to: - medical supply chains - TRIPS Waiver

CPT

- S. 150, "Affordable Prescriptions for Patients Act of 2023", regarding all provisions. - S. 79, "Interagency Patent Coordination and Improvement Act of 2023", regarding all provisions.

TAX

Taxation/Internal Revenue Code

- Issues related to implementation of global tax rules, R&D expensing, and the President's budget

Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · fourth_quarter · Q4

Firm income: —Client expense: $2,270,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

- HR 5214, "To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements.", regarding expenditures from HSAs, FSAs, and health reimbursement arrangements for dietary supplements - Issues related to Health Spending Accounts & Flexible Spending Accounts - Issues related to corporate tax provisions of reconciliation bill - U.S. Treasury policy and negotiating positions related to tax at the Organisation for Economic Co-operation and Development ("OECD") - Issues related to US Treasury implementation of new corporate alternative minimum tax - Issues related to WTO TRIPS agreement

TRD

Trade (domestic/foreign)

- HR 2884/S 1435, Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act, regarding all provisions - Issues related to mandatory supply chain requirements, including under "Buy America" - Issues related to waiver of WTO TRIPS related to COVID response

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · third_quarter · Q3

Firm income: —Client expense: $2,170,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, FDA review of certain changes to software in medical devices or predetermined change control plans - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021" - S 3799 - "PREVENT Pandemics Preparedness Act" - HR 3932/S 2079 - "PASTEUR Act of 2021" - HR 5376 - "Inflation Reduction Act", regarding provisions on prescription drugs - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · second_quarter · Q2

Firm income: —Client expense: $1,050,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, FDA review of certain changes to software in medical devices or predetermined change control plans - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · first_quarter · Q1

Firm income: —Client expense: $2,320,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

- HR 2096/S 2472, "Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act", regarding all provisions - HR 5214, regarding expenditures from HSAs, FSAs, and health reimbursement arrangements for dietary supplements - Issues related to Health Spending Accounts & Flexible Spending Accounts - Issues related to corporate tax provisions of reconciliation bill - U.S. Treasury policy and negotiating positions related to tax at the Organisation for Economic Co-operation and Development ("OECD")

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, legislation to expand access to adult vaccines under Medicare Part B, regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act" - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "The Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, No PFAS in Cosmetics Act - HR 2467, PFAS Action Act of 2021 - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation - Issues related to FDA review of certain changes to software in medical devices or predetermined change control plans - Issues related to HR ___, "Medical Device User Fee Amendments of 2022"

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2021 · fourth_quarter · Q4

Firm income: —Client expense: $880,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

- Issues related to mandatory supply chain requirements, including under "Buy America" - Issues related to waiver of WTO TRIPS related to COVID response - HR 2884/S 1435, Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - Issues related to prescription drug pricing - Issues pertaining to Medicare coverage of vaccines - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - HR 446, Expressing support for the goals and ideals of National Stroke Awareness Month - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act" - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - Issues related to clinical research diversity - S 3394, "The Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding all provisions

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2021 · third_quarter · Q3

Firm income: —Client expense: $1,920,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

TAX

Taxation/Internal Revenue Code

- Issues related to Health Spending Accounts & Flexible Spending Accounts - Issues related to corporate tax provisions of reconciliation bill - U.S. Treasury policy and negotiating positions related to tax at the Organisation for Economic Co-operation and Development ("OECD") - HR 2096/S 2472 "Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act", regarding all provisions.

HCR

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2021 · second_quarter · Q2

Firm income: —Client expense: $800,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

TAX

Taxation/Internal Revenue Code

- HR (BILL NUMBER TBD), "Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases (SACKLER) Act", regarding all provisions - Issues related to Health Spending Accounts & Flexible Spending Accounts - Issues related to supply chain investment incentives - Issues related to international tax framework - Administration budget and infrastructure proposal related to tax - U.S. Treasury policy and negotiating positions related to tax at the Organisation for Economic Co-operation and Development ("OECD")

HCR

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2021 · first_quarter · Q1

Firm income: —Client expense: $2,480,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to contact lens safety - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis

TAX

Taxation/Internal Revenue Code

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2020 · fourth_quarter · Q4

Firm income: —Client expense: $1,450,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

CPT

- Patent Trade Office reforms - H.R.1499 "Protecting Consumer Access to Generic Drugs Act of 2019", regarding all provisions - S. 1419, "Early Participation in Regulations Act of 2019", regarding all provisions

TRD

Trade (domestic/foreign)

-Issues related to new tariff proclamations and retaliation. - Issues related to mandatory supply chain requirements, including under Buy America. - H.R.6930, "MADE in America Act of 2020", regarding all provisions - 301 investigation of countries related to foreign digital service taxes and potential tariff retaliation

HCR

Health Issues

- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions - S. 726 - Personal Care Products Safety Act, regarding all provisions - Issues related to the regulation of over-the-counter drugs - Issues related to cosmetic regulatory reform - Issues related to cosmetic animal testing - Issues related to biosimilars - Issues related to maternal mortality - Issues related to contact lens safety - Issues related to medical product communications - Issues related to medical product review - Issues related to ingredient safety - Issues related to diversity in clinical trials - Issues related to health care pricing transparency - Issues related to peripheral artery disease - H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - Issues related to drug importation - S. 2543, "Prescription Drug Pricing Reduction Act of 2019", regarding all provisions - H.R. 19, "Lower Costs, More Cures Act of 2019", regarding all provisions - H.R. 748/ S. 3458, "'Coronavirus Aid, Relief, and. Economic Security Act'', regarding all provisions - H.R. 6074, "Coronavirus Preparedness and Response Supplemental Appropriations Act", regarding all provisions - H.R. 6201, "Families First Coronavirus Response Act", regarding all provisions - H.R. 3975, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 5663, the Safeguarding Therapeutics Act, regarding all provisions - Issues related to counterfeit health care goods - S. 3468, Preventing Essential Medical Device Shortages Act of 2020 - Issues related to counterfeit medical devices and combination products and authority to destroy counterfeit medical products - Issues related to reporting medical device shortages - Issues related to pandemic response - S. 2740, "Over the Counter Monograph Safety, Innovation, and Reform Act of 2019", regarding all provisions - H.R. 5279, "Cosmetic Safety Enhancement Act", regarding all provisions - H.R. 4296, "Safe Cosmetics and Personal Care Products Act of 2019", regarding all provisions - Issues related to social determinants of health - H.R. 5076/S. 1872, "Protecting Seniors Through Immunization", regarding all provisions - H.R.6062, "To amend certain provisions in the Federal Food, Drug, and Cosmetic Act relating to the discontinuance or interruption in the production of life-saving drugs so as to apply such provisions with respect to life-saving devices, and for other purposes", regarding all provisions. - H.R.6952, "To direct the President to appoint a Medical Supplies Response Coordinator to coordinate the efforts of the Federal Government regarding the supply and distribution of certain supplies and equipment relating to COVID-19", regarding all provisions - S.3942, "Securing America's Medical Supply Chain and Advancing the Production of Life Saving Medicines Act", regarding all provisions - S.3945, "Bring Entrepreneurial Advancements To Consumers Here In North America Act", regarding all provisions - S.3780, "HOME Act", regarding all provisions - S.3781, "PART Act", regarding all provisions - Issues related to diversity in clinical trials - Issues related to 340B - S.4613, The Contact Lens Rule Modernization Act, regarding all provisions - H.R.3107, "Improving Seniors Timely Access to Care Act of 2019, regarding all provisions - Executive Order 13948: Lowering Drug Prices by Putting America First - Executive Order 13939: Lowering Prices for Patients by Eliminating Kickbacks to Middlemen - Executive Order 13938: Increasing Drug Importation To Lower Prices for American Patients - Executive Order 13937: Access to Affordable Life-Saving Medications -H.R.133 - Consolidated Appropriations Act, 2021, including legislation regarding average sales price (ASP) reporting requirements for certain hyaluronic acid (HA) products that are classified as devices, but reimbursed as drugs under Medicare Part B

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2020 · third_quarter · Q3

Firm income: —Client expense: $860,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TAX

Taxation/Internal Revenue Code

- Issues related to spending and linked to corporate tax rate - H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions - H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions - Issues related to CFC look through. - Issues related to the implementation of the Tax Cut and Jobs Act of 2017 - H.R. 1922/S. 1089 -"Restoring Access to Medication Act of 2019", regarding all provisions. - H.R. 748/ S. 3458, "Coronavirus Aid, Relief, and. Economic Security Act", regarding tax provisions and future stimulus bills. - Issues related to supply chain investment incentives. - Tax issues related to Puerto Rico

TRD

Trade (domestic/foreign)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2020 · second_quarter · Q2

Firm income: —Client expense: $1,760,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2020 · first_quarter · Q1

Firm income: —Client expense: $1,480,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2019 · fourth_quarter · Q4

Firm income: —Client expense: $1,350,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TAX

Taxation/Internal Revenue Code

- Issues related to miscellaneous tax bills. - Issues related to spending and linked to corporate tax rate - H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions - H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions - Issues related to replacing G1LT1 global average method with a per country minimum. - Issues related to CFC look through. - Issues related to the Tax Cut and Jobs Act of 2017 - H.R. 1922/S. 1089 -"Restoring Access to Medication Act of 2019", regarding all provisions. - H.R. 2207/S. 693 "Protect Medical Innovation Act of 2019", regarding all provisions. - Issues related to the repeal of the medical device tax and the cadillac tax

TRD

Trade (domestic/foreign)

-Issues related to the NAFTA/USMCA renegotiation issues. -Issues related to new tariff proclamations and retaliation.

CPT

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2019 · third_quarter · Q3

Firm income: —Client expense: $810,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

CPT

- Patent Trade Office reforms - H.R.1520-Purple Book Continuity Act of 2019, regarding all provisions - H.R.1503-Orange Book Transparency Act of 2019, regarding all provisions - H.R.1499-Protecting Consumer Access to Generic Drugs Act of 2019, regarding all provisions - S.659 -Biologic Patent Transparency Act, regarding all provisions.

TRD

Trade (domestic/foreign)

-Issues related to the NAFTA/USMCA renegotiation issues. -Issues related to new tariff proclamations and retaliation.

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2019 · second_quarter · Q2

Firm income: —Client expense: $2,150,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TAX

Taxation/Internal Revenue Code

- Issues related to miscellaneous tax bills. - Issues related to spending and linked to corporate tax rate - H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions - H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions - Issues related to replacing G1LT1 global average method with a per country minimum. - Issues related to CFC look through. - Issues related to the Tax Cut and Jobs Act of 2017 - H.R. 1922/S. 1089 - A bill to amend the Internal Revenue Code of 1986 to repeal the amendments made by the Patient Protection and Affordable Care Act which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements, regarding all provisions.

TRD

Trade (domestic/foreign)

-Issues related to the NAFTA/USMCA renegotiation issues. -Issues related to new tariff proclamations and retaliation.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2019 · first_quarter · Q1

Firm income: —Client expense: $1,440,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

CPT

- Patent Trade Office reforms - H.R.1520-Purple Book Continuity Act of 2019, regarding all provisions - H.R.1503-Orange Book Transparency Act of 2019, regarding all provisions - H.R.1499-Protecting Consumer Access to Generic Drugs Act of 2019, regarding all provisions - S.649 -Biologic Patent Transparency Act, regarding all provisions.

TAX

Taxation/Internal Revenue Code

- Issues related to miscellaneous tax bills. - Issues related to spending and linked to corporate tax rate - H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions - H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions - Issues related to replacing G1LT1 global average method with a per country minimum. - Issues related to CFC look through. - Issues related to the Tax Cut and Jobs Act of 2017 - H.R. 1922/S. 1089 - A bill to amend the Internal Revenue Code of 1986 to repeal the amendments made by the Patient Protection and Affordable Care Act which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements, regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2018 · fourth_quarter · Q4

Firm income: —Client expense: $2,340,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

LBR

Labor Issues/Antitrust/Workplace

- Issues related to shareholder reform. - Issues related to proxy advisory firm reform. - PL 115-97, "Tax Cuts & Jobs Act", regarding provisions related to SEC notification.

CPT

- S.1390/H.R.5340, "STRONGER Patents Act of 2018", regarding all provisions. - Patent Trade Office reforms

HCR

Health Issues

- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions. - S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions. - H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions. - H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions. - S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions. - Issues regarding drug pricing. - Issues related to diagnostic reform. - S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions - S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions - S 204/HR 878, Right to Try Act of 2017, regarding all provisions - HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions - HR 1703, Medical Product Communications Act of 2017, regarding all provisions - Issues related to VA procurement of medical devices - HR 2474, Medical Product Review Harmonization Act, regarding all provisions - HR 2144, Risk Based Classification of Accessories Act - Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects - S.1113, "Personal Care Products Safety Act", regarding all provisions - HR 2790, "Humane Cosmetics Act", regarding all provisions - HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions - Issues regarding medical device repeal - Issues regarding NIH Funding - HR 2164, "Medical Device Safety Act", regarding all provisions - Issues related to 340B - Issues related to HIV vaccines - S. 2852, "Pandemic & All Hazards Preparedness and Advancing Innovations Act of 2018", regarding all provisions. - Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs. (House version) - HR 5492, "MOTHER Act of 2018", regarding all provisions. - Issues related to access to essential surgery - Issues related to contact lens safety - HR 6, "SUPPORT for Patients and Communities Act", regarding all provisions. - S. 2315, "Over-the-Counter Drug Safety, Innovation, and Reform Act", regarding all provisions. - HR 5333 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018", regarding all provisions. - Issues related to antimicrobial resistance - Issues related to regulations on medication product packaging - H.R. 6294, " Re-Valuing Anti-Microbial Products Act of 2018", regarding all provisions - H.R. 1318, "Preventing Maternal Deaths Act of 2018", regarding all provisions

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2018 · third_quarter · Q3

Firm income: —Client expense: $1,980,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

TRD

Trade (domestic/foreign)

- Issues related to the NAFTA renegotiation issues. - Issues related to miscellaneous trade bills. - Issues related to new tariff proclamations and retaliation.

CPT

- S.1390/H.R.5340, "STRONGER Patents Act of 2018", regarding all provisions. - Patent Trade Office reforms

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2018 · second_quarter · Q2

Firm income: —Client expense: $870,000Open original LDA filing ↗

Assigned issues and filing targets (5 issues)

HCR

Health Issues

- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions. - S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions. - H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions. - H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions. - S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions. - Issues regarding drug pricing. - Issues related to diagnostic reform. - S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions - S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions - S 204/HR 878, Right to Try Act of 2017, regarding all provisions - HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions - HR 1703, Medical Product Communications Act of 2017, regarding all provisions - Issues related to VA procurement of medical devices - HR 2474, Medical Product Review Harmonization Act, regarding all provisions - HR 2144, Risk Based Classification of Accessories Act - Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects - S.1113, "Personal Care Products Safety Act", regarding all provisions - HR 2790, "Humane Cosmetics Act", regarding all provisions - Issues related to over the counter medicine regulatory reform - HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions - Issues regarding medical device repeal - Issues regarding NIH Funding - HR 2164, "Medical Device Safety Act", regarding all provisions - Issues related to 340B - Issues related to HIV vaccines - S. 2852, "Pandemic & All Hazards Preparedness and Advancing Innovations Act of 2018", regarding all provisions. - Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs. (House version) - HR 5492, "MOTHER Act of 2018", regarding all provisions. - Issues related to access to essential surgery - Issues related to contact lens safety

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2018 · first_quarter · Q1

Firm income: —Client expense: $1,370,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

LBR

Labor Issues/Antitrust/Workplace

- Issues related to shareholder reform. - Issues related to proxy advisory firm reform. - PL 115-97, "Tax Cuts & Jobs Act", regarding provisions related to SEC notification.

HCR

Health Issues

- S. 469/H.R. 1245, "Affordable and Safe Prescription Drug Importation Act", regarding all provisions. - S. 771/H.R. 1776, "Improving Access To Affordable Prescription Drugs Act", regarding all provisions. - H.R. 575, "Cosmetic Modernization Amendments of 2017", regarding all provisions. - H.R. 1271, "DXM Abuse Prevention Act of 2017", regarding all provisions. - S. 404/H.R. 1736, "To amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications.", regarding all provisions. - Issues regarding drug pricing. - Issues related to diagnostic reform. - Issues related to blood glucose meters. - S 260/SJ Res 17/HR 849, Protecting Seniors' Access to Medicare Act of 2017, regarding all provisions - S 251/SJ Res 16, Protecting Medicare from Executive Action Act of 2017, regarding all provisions - S 204/HR 878, Right to Try Act of 2017, regarding all provisions - HR 2026, Pharmaceutical Information Exchange Act, regarding all provisions - HR 1703, Medical Product Communications Act of 2017, regarding all provisions - Issues related to VA procurement of medical devices - HR 2474, Medical Product Review Harmonization Act, regarding all provisions - HR 2144, Risk Based Classification of Accessories Act - Issues related to AMA resolution 208(A-16) regarding attorney ads on drug side effects - S.1113, "Personal Care Products Safety Act", regarding all provisions - HR 2790, "Humane Cosmetics Act", regarding all provisions - Issues related to over the counter medicine regulatory reform - HR 3271, "Protecting Access to Diabetes Supplies Act", regarding all provisions - Issues regarding medical device repeal - Issues regarding NIH Funding - HR 2164, "Medical Device Safety Act", regarding all provisions - Issues related to 340B - Issues related to HIV vaccines - Issues related to reauthorization of the Pandemic All-Hazards Preparedness Act programs. - HR 5492, "MOTHER Act of 2018", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2017 · fourth_quarter · Q4

Firm income: —Client expense: $3,650,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

- Issues related to the Trans-Pacific Partnership Agreement. - Issues related to the NAFTA renegotiation issues.

TAX

Taxation/Internal Revenue Code

- S.84/H.R.394, "Restoring Access to Medication Act of 2017", regarding all provisions. - Issues related to tax reform. - Issues related to Mobile Workforce legislation. - Issues related to Cadillac Tax. - Issues related to OECD tax reporting. - Issues related to Puerto Rico tax treatment. - Issues related to House Blueprint - Issues related to the President's tax plan.

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2017 · third_quarter · Q3

Firm income: —Client expense: $810,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

- S.84/H.R.394, "Restoring Access & Medication Act of 2017", regarding all provisions. - Issues related to tax reform. - Issues related to Mobile Workforce legislation. - Issues related to Cadillac Tax. - Issues related to OECD tax reporting. - Issues related to Puerto Rico tax treatment. - Issues related to House Blueprint - Issues related to the President's tax plan.

TRD

Trade (domestic/foreign)

- Issues related to the Trans-Pacific Partnership Agreement. - Issues related to the NAFTA renegotiation issues.

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2017 · second_quarter · Q2

Firm income: —Client expense: $1,290,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

TRD

Trade (domestic/foreign)

- Issues related to the Trans-Pacific Partnership Agreement. - Issues related to the NAFTA renegotiation issues.

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2017 · first_quarter · Q1

Firm income: —Client expense: $1,060,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2016 · fourth_quarter · Q4

Firm income: —Client expense: $1,460,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

- Issues related to Trans-Pacific Partnership agreement. - Issues related to Transatlantic Trade and Investment Partnership. - Issues related to the appointment of a dedicated healthcare trade official

TAX

Taxation/Internal Revenue Code

- HR 1270/S 709, "Restoring Access to Medication Act of 2015", regarding all provisions. - Issues related to tax reform. - Issues related to CFC Look through permanency. - Issues related to R&D credit. - Issues related to Mobile Workforce legislation. - Issues related to Cadillac Tax. - Issues related to OECD tax reporting. - Issues related to Repatriation holiday. - Issues related to Puerto Rico tax treatment. - Issues related to flexible spending accounts tax treatment. - HR 4900/ HR 5278/ S 2328, "PROMESA", regarding provisions related to Puerto Rico debt restructuring. - H.Res 770, "Providing for consideration of the bill (H.R. 5278) to establish an Oversight Board to assist the Government of Puerto Rico, including instrumentalities, in managing its public finances, and for other purposes.", regarding all provisions. - Issues related to treasury debt/equity rules.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2016 · third_quarter · Q3

Firm income: —Client expense: $890,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

TRD

Trade (domestic/foreign)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2016 · second_quarter · Q2

Firm income: —Client expense: $2,040,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

TRD

Trade (domestic/foreign)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2016 · first_quarter · Q1

Firm income: —Client expense: $1,140,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TRD

Trade (domestic/foreign)

TAX

Taxation/Internal Revenue Code

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2015 · fourth_quarter · 4A

Firm income: —Client expense: $1,210,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TRD

Trade (domestic/foreign)

TAX

Taxation/Internal Revenue Code

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2015 · fourth_quarter · Q4

Firm income: —Client expense: $1,260,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TRD

Trade (domestic/foreign)

TAX

Taxation/Internal Revenue Code

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2015 · third_quarter · Q3

Firm income: —Client expense: $780,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TRD

Trade (domestic/foreign)

- Issues related to Trade Promotion Authority. - Issues related to Trans-Pacific Partnership agreement. - Issues related to Transatlantic Trade and Investment Partnership. - Issues related to APEC Healthcare trade project. - Issues related to Trade Promotion Authority. - Issues related to the appointment of a dedicated healthcare trade official

TAX

Taxation/Internal Revenue Code

- HR 1270/S 709, "Restoring Access to Medication Act of 2015", regarding all provisions. - Issues related to tax reform. - Issues related to Look through permanency. - Issues related to R&D credit permanency. - Issues related to Mobile Workforce. - Issues related to Cadillac Tax. - Issues related to OECD tax reports. - Issues related to Repatriation holiday.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2015 · second_quarter · Q2

Firm income: —Client expense: $2,420,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

TRD

Trade (domestic/foreign)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2015 · first_quarter · Q1

Firm income: —Client expense: $1,820,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TRD

Trade (domestic/foreign)

TAX

Taxation/Internal Revenue Code

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2014 · fourth_quarter · Q4

Firm income: —Client expense: $1,400,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TAX

Taxation/Internal Revenue Code

- Issues regarding tax reform. - HR 1248, "Family Health Care Flexibility Act", regarding all provisions. - Issues related to tax legislation. - Issues related to Ways and Means and Senate Finance tax reform discussion drafts.- HR 1129 / S 1645, "Mobile Workforce State Income Tax Simplification Act of 2013", regarding all provisions. - HR 2992, "Business Activity Tax Simplification Act", regarding all provisions. - HR 2835, "Restoring Access to Medication Act", regarding all provisions. - Issues related to OECD tax project.

TRD

Trade (domestic/foreign)

- Issues related to current and future trade negotiations. - Issues related to TransPacific Partnership trade negotiations. - Issues related to TransAtlantic Trade and Investment Partnership negotiations. - Issues related to Trade Promotion Authority.- Issues related to dedicated USG healthcare trade position.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2014 · third_quarter · Q3

Firm income: —Client expense: $1,350,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing. - Issues related to 21st Century Cures. - Issues related to Medicare beneficiary access. - Issues related to mobile medical applications and digital healthcare. - Issues related to FDA draft guidances on blood glucose meters. - HR 4895/ S 2902, "The Microbead Free Waters Act of 2014", regarding all provisions. - Issues related to the expanded use of unapproved drugs. - Issues related to combination products. - Issues related to the PROTECT Act (bill number pending), specifically medical mobile applications. - Issues related to Government Health Care Exclusion/ Debarment (bill number pending)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2014 · second_quarter · Q2

Firm income: —Client expense: $1,060,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TAX

Taxation/Internal Revenue Code

FIN

Financial Institutions/Investments/Securities

- HR 1135, "Burdensome Data Collection Relief Act", regarding all provisions.

TRD

Trade (domestic/foreign)

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2014 · first_quarter · Q1

Firm income: —Client expense: $2,110,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - HR 2375, "Competitive Bidding for DME Delay", regarding all provisions. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - HR 2085, "Diagnostic Payment Reform", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - HR 4015, "SGR Repeal and Medicare Provider Payment Modernization Act of 2014", regarding all provisions. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2013 · fourth_quarter · Q4

Firm income: —Client expense: $860,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - HR 2375, "Competitive Bidding for DME Delay", regarding all provisions. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - HR 2085, "Diagnostic Payment Reform", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - S. 1871, "SGR Repeal and Medicare Beneficiary Access Act of 2013", regarding all provisions. - Issues related to health care associated infections. - S. 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2013 · third_quarter · Q3

Firm income: —Client expense: $1,280,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TRD

Trade (domestic/foreign)

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2013 · first_quarter · 1A

Firm income: —Client expense: $2,070,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2013 · second_quarter · Q2

Firm income: —Client expense: $1,360,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

FIN

Financial Institutions/Investments/Securities

- HR 1135, "Burdensome Data Collection Relief Act", regarding all provisions.

TRD

Trade (domestic/foreign)

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2013 · first_quarter · Q1

Firm income: —Client expense: $1,430,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

FIN

Financial Institutions/Investments/Securities

- HR 1135, "Burdensome Data Collection Relief Act", regarding all provisions.

TRD

Trade (domestic/foreign)

TAX

Taxation/Internal Revenue Code

- Issues regarding tax reform. - HR 1248, "Family Health Care Flexibility Act", regarding all provisions. - Issues related to tax legislation. - Issues related to Ways and Means tax reform discussion draft.- HR 523, "Protect Medical Innovation Act of 2013", regarding all provisions. - HR 1295, "Medical Device Tax Elimination Act", regarding all provisions. - S 232, "Medical Device Access and Innovation Protection Act", regarding all provisions. - HR 1129, "Mobile Workforce State Income Tax Simplification Act of 2013", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2012 · fourth_quarter · Q4

Firm income: —Client expense: $880,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

- Issues regarding tax reform. - HR 605, "The Patients' Freedom to Choose Act", regarding all provisions. - HR 436, "Protect Medical Innovation Act of 2011", regarding all provisions. - HR 488, "Save Our Medical Devices Act of 2011", regarding all provisions. - HR 734, "To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes", regarding all provisions. - S 17, "Medical Device Access and Innovation Protection Act", regarding all provisions. - S 262, "A bill to repeal the excise tax on medical device manufacturers", regarding all provisions. - HR 942, "American Research and Competitiveness Act of 2011", regarding all provisions - Issues related to tax legislation. - Issues related to the President's proposed "Job Bill" (2011) - S 1368/ HR 2529, "Restoring Access to Medication Act", regarding all provisions. - S 1584, "Drug Safety and Accountability Act of 2011", regarding all provisions. - HR 2245, "Preserving Access to Life-Saving Medication Act", regarding all provisions. - Issues related to Ways and Means tax reform discussion draft. - HR 2735, "To amend the Internal Revenue Code of 1986 to make permanent the look-through treatment of payments between related controlled foreign corporations", regarding all provisions. - S 1577, "Greater Research Opportunities With Tax Help Act", regarding all provisions. - PL 112-96, "Middle Class Tax Relief and Job Creation Act of 2012", provisions regarding Medicare clinical laboratory services. - HR 1864, "Mobile Workforce State Income Tax Simplification Act of 2011", regarding all provisions. - S 2091, "United States Job Creation and International Tax Reform Act of 2012", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2012 · third_quarter · Q3

Firm income: —Client expense: $1,420,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

- Korea-US Free Trade Agreement - Issues related to current and future trade negotiations. - TransPacific Partnership trade negotiations. - Pending legislation regarding the extension of permanent normal trade relations to Russia.

FIN

Financial Institutions/Investments/Securities

- HR 1062, "The Burdensome Data Collection Relief Act", regarding all provisions.

TAX

Taxation/Internal Revenue Code

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2012 · second_quarter · Q2

Firm income: —Client expense: $1,200,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TAX

Taxation/Internal Revenue Code

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2012 · first_quarter · Q1

Firm income: —Client expense: $2,260,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

- Korea-US Free Trade Agreement - Issues related to current and future trade negotiations. - TransPacific Partnership trade negotiations. - Pending legislation regarding the exension of permanent normal trade relations to Russia.

TAX

Taxation/Internal Revenue Code

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2011 · fourth_quarter · Q4

Firm income: —Client expense: $930,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

TRD

Trade (domestic/foreign)

- Korea-US Free Trade Agreement - Issues related to current and future trade negotiations. - TransPacific Partnership trade negotiations. - Pending legislation regarding the exension of permanent normal trade relations to Russia.

FIN

Financial Institutions/Investments/Securities

- HR 1062, "The Burdensome Data Collection Relief Act", regarding all provisions.

TAX

Taxation/Internal Revenue Code

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2011 · third_quarter · Q3

Firm income: —Client expense: $1,770,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TRD

Trade (domestic/foreign)

- Korea-US Free Trade Agreement - Issues related to current and future trade negotiations. - TransPacific Partnership trade negotiations.

TAX

Taxation/Internal Revenue Code

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, "To allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.", regarding all provisions - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021", regarding all provisions - S 3799 - "PREVENT Pandemics Act", regarding all provisions - HR 3932/S 2076 - "PASTEUR Act of 2021", regarding all provisions - HR 5376 - "Inflation Reduction Act", regarding provisions on drug pricing and provisions related to revenue - HR 7559 - Prescription Information Modernization Act of 2022, regarding all provisions - HR 2617 - "Consolidated Appropriations Act, 2023", regarding provisions related to pharmaceuticals, medical devices, mental health, and tax - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation

HCR

Health Issues

HCR

Health Issues

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 2994, "DXM Abuse Prevention Act of 2016", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - S. 1014, "Personal Care Products Safety Act", regarding all provisions. - S. 2777, "Contact lens Consumer Health Protection Act of 2016", regarding all provisions. - Issues related to Medicare Part B Demo - Issues related to Expanded Access in Senate Innovation Package - Issues related to Self monitoring of blood glucose meters. - HR 4075, "Cosmetic Modernization Amendments of 2015", regarding all provisions. - HR 1192, "National Clinical Care Commission Act", regarding all provisions.

HCR

Health Issues

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - HR 2085, "Diagnostic Payment Reform", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - HR 4015, "SGR Repeal and Medicare Provider Payment Modernization Act of 2014", regarding all provisions. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing. - Issues related to 21st Century Cures. - Issues related to Medicare beneficiary access. - Issues related to mobile medical applications and digital healthcare. - Issues related to FDA draft guidances on blood glucose meters. - HR 4895, "The Microbead Free Waters Act of 2014", regarding all provisions. - Issues related to the expanded use of unapproved drugs.